Grants and Contributions:
Title:
Development of a Quantitative Assay to Measure Drug Metabolites for Cancer Treatment.
Agreement Number:
999524
Agreement Value:
$185,900.00
Agreement Date:
Dec 5, 2022 - Mar 31, 2024
Description:
Development of a safe, effective and affordable drug biomarker test to assess and monitor response to cancer therapy.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1P 4P5
Reference Number:
172-2022-2023-Q3-999524
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
796635662
Recipient Type:
For-profit organization
Recipient's Operating Name:
Biomark Diagnostic Solutions inc.
Recipient's Legal Name:
Solutions de Diagnostic Biomark inc.
Federal Riding Name:
Québec
Federal Riding Number:
24059
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512